• 제목/요약/키워드: Phosphodiesterase-5 inhibitor

검색결과 64건 처리시간 0.027초

약용식물로 부터의 Phosphodiesterase 5 저해제 검색 (Screening of Herbal Medicines for Phosphodiesterase 5 Inhibitor)

  • 이경호;김병수;이기형
    • 생약학회지
    • /
    • 제43권2호
    • /
    • pp.184-191
    • /
    • 2012
  • The aim of this study was to explore the potent phosphodiesterase type 5 (PDE %) inhibitor from various herbal medicines for erectile dysfunctions. In this study, 61 herbal medicines, which were extracted with ethanol, have been investigated with PDE 5 assay using enzyme inhibitory activity on 22 species of herbal medicines. Of these, 5 species of herbal medicines, Cnidium monieri, Cuscuta chinensis, Epimedium koreanum, Morinda officinalis, and Tribulus terrestris were exhibited stronger inhibitory effect against phosphodiesterase 5 (PDE 5) among 61 species; Cnidium monieri ($IC_{50}=33.7{\mu}g/ml$), Cuscuta chinensis ($IC_{50}=65.7{\mu}g/ml$), Epimedium koreanum ($IC_{50}=90.3{\mu}g/ml$), Morinda officinalis ($IC_{50}=48.7{\mu}g/ml$) and Tribulus terrestris ($IC_{50}=32.5{\mu}g/ml$).

The Effect of Phosphodiesterase-4-Specific Inhibitor in the Rat Model of Spinal Nerve Ligation

  • Kim, Sung-Hoon;Park, Bit-Na-Ri;Kim, Seok-Won
    • Journal of Korean Neurosurgical Society
    • /
    • 제50권2호
    • /
    • pp.109-113
    • /
    • 2011
  • Objective : Peripheral neuropathy is characterized by hyperalgesia, spontaneous burning pain, and allodynia. The purpose of this study was to investigate the effect of rolipram, a phosphodiesterase-4-specific inhibitor, in a segmental spinal nerve ligation model in rats. Methods : Both the L5 and L6 spinal nerves of the left side of the rats were ligated. Phosphodiesterase-4 inhibitor (rolipram) and saline (vehicle) were administered intraperitoneally. We measured mechanical allodynia using von Frey filaments and a nerve conduction study. Results : The mechanical allodynia, which began to manifest on the first day, peaked within 2 days. Multiple intraperitoneal injections of rolipram ameliorated the mechanical allodynia. Furthermore, an intraperitoneal administration of rolipram improved the development of pain behavior and nerve conduction velocity. Conclusion : This study suggests that the phosphodiesterase-4 inhibitor, rolipram, alleviates mechanical allodynia induced by segmental spinal nerve ligation in rats. This finding may have clinical implications.

Effects of a New Selective Phosphodiesterase Type 5 Inhibitor, KJH-1002, on the Relaxation of Rabbit Corpus Cavernosum Tissue

  • Cho, Eun-Young;Chung, Sung-Hyun;Kim, Joong-Hyup;Kim, Dong-Hyun;Jin, Cang-Bae
    • Biomolecules & Therapeutics
    • /
    • 제11권4호
    • /
    • pp.232-237
    • /
    • 2003
  • The present study examined functional effects of a new selective phosphodiesterase type 5 inhibitor, 1-[4-ethoxy-3-(6,7-dihydro-1-methyl-7-thioxo-3-propyl-1H-pyrazolo[ 4,3]pyrimidin-5-yl)phenylsulphonyl]-4-methyl piperazine (KJH-1002), in the isolated rabbit corpus cavernosum (RCC). Relaxing effects of KJH-1002 were also compared with those of sildenafil, which is currently used as an oral therapy for penile erectile dysfunction. In the isolated RCC precontracted with phenylephrine, both KJH-1002 and sildenafil in the concentration range of 1 to 1000 nM, produced a comparable potentiation of the electical field stimulation-induced relaxation in a concentration-dependent manner. In the sodium nitroprusside (SNP)-induced relaxation, the $IC_{50}$/ values, concentrations of SNP required to produce a 50% relaxation of the phenylephrine-induced contraction, were significantly decreased to the similar extent by treatments with KJH-1002 and sildenafil. The results suggest that a new selective phosphodiesterase type 5 inhibitor, KJH-1002, has an augmentative effect on penile erection comparable to that of sildenafil and can be useful for the treatment of erectile dysfunction.

Erectogenic Effect of the Selective Phosphodiesterase Type 5 Inhibitor DA-8159

  • Oh, Tae-Young;Kang, Kyung-Koo;Ahn, Byoung-Ok;Yoo, Moo-hi;Kim, Won-Bae
    • Archives of Pharmacal Research
    • /
    • 제23권5호
    • /
    • pp.471-476
    • /
    • 2000
  • DA-8159, a new phosphodiesterase 5 inhibitor, was assessed for its erectogenic potential by a penile erection test in rats, the relaxation of isolated rabbit corpus cavernosum (CC), and estimation of the intracavernous pressure (ICP) in the anesthetized dog. Oral administration of DA-8159 (0.3 to 1 ${\mu}g/kg$ ) increased the number of erections in rats with increasing dosage, with the highest penile erection index at 10 ${\mu}g/kg$ DA-8159 induced the relaxation of phenylephrine (PHE)-induced contractions in the rabbit CC and decreased the $IC_{50}$ of the nitric oxide donor sodium nitroprusside (SNP) in a dose-dependent fashion. In pentobarbital-anesthetized dogs, the intravenous administration of DA-8159 (1~300 ${\mu}g/kg$ ) potentiated the increase in ICP induced by the intracavernosal SNP in a dose-related manner. These findings suggest that DA-8159 has significant therapeutic potential in the treatment of erectile dysfunction.

  • PDF

DA-8159, a Potent cGMP Phosphodiesterase Inhibitor, Attenuates Monocrotaline-Induced Pulmonary Hypertension in Rats

  • Kang, Kyung-Koo;Ahn, Gook-Jun;Sohn, Yong-Sung;Ahn, Byoung-Ok;Kim, Won-Bae
    • Archives of Pharmacal Research
    • /
    • 제26권8호
    • /
    • pp.612-619
    • /
    • 2003
  • In this study, we evaluated the effects of oral administration of DA-8159, a selective phosphodiesterase-5 inhibitor, on the development of pulmonary hypertension (PH) induced by monocrotaline (MCT). Rats were administered either MCT (60 mg/kg) or saline. MCT-treated rats were divided into three groups and received orally administered vehicle, or 1 mg/kg or 5 mg/kg of DA-8159, twice a day for twenty-one days. The MCT group demonstrated increased right ventricular weights, medial wall thickening in the pulmonary arteries, myocardial fibrosis and the level of plasma cyclic guanosine monophosphate (cGMP), along with decreased body weight gains. However, DA-8159 markedly and dose-dependently reduced the development of right ventricular hypertrophy and medial wall thickening. DA-8159 also amplified the increase in plasma cGMP level and significantly increased the level of lung cGMP, compared with the MCT group. Although the body weight gain was still lower from the saline-treated control group, DA-8159 demonstrated a significant increase in body weight gains, in both 1 mg/kg and 5 mg/kg groups, when compared with the MCT group. In myocardial morphology, MCT-induced myocardial fibrosis was markedly prevented by DA-8159. These results suggest that DA-8159 may be a useful oral treatment option for PH.

미생물 효소에 의한 핵산 및 그의 관련물질의 분해에 관한 연구 (Studies on Degradation of Nucleic acid and Related Compounds by Microbial Enzymes)

  • 김상순
    • Applied Biological Chemistry
    • /
    • 제13권2호
    • /
    • pp.111-129
    • /
    • 1970
  • 핵산 및 그 관련물질 연구의 일환으로서 미생물 효소에 의하여 핵산을 분해하여 5'-mononucleotides 생성을 목적으로 미생물에서 5'-phosphodiesterase 생성균주를 얻기위하여 전국 각지 76개 지역에서 논, 밭, 산, 하천의 토양 그리고 퇴비, 누룩, 메주 등 시료 210종을 수집하였다. 이 수집 시료로 부터 dilution pour plate method 로서 Aspergillus속 240주, Penicillium속 232주, Neurospora속, 19주, Monascus속 16주, 그리고 Streptomyces속 265주로 총 758주를 순수 분리하였다. 분리된 모든 균주에 대하여 RNA-depolymerase 균의 crude enzyme 중에는 5'-AMP deaminase가 공존하고 있으므로 효소반응 중에 RNA 가 5'-mononucleotide로 분해 축적하는 동안에 5'-AMP의 adenine의 6위치에 붙은 $NH_2$기를 탈아미노하여 hypoxanthine으로 하기 때문에 5'-IMP 로 되는 것이라 생각된다. 분리 동정 된 Penicillium citreo-viride PO 2-11 strain과 Streptomyces aureus SOA 4-21 strain 이 생성한 5'-phosphodiesterase 로서 RNA를 효소 분해하여 5'-mononucleotide 의 정량한 결과는 Table 10과 같다. productivities를 1차 screening 하고 5'-phosphodiesterase productivities로서 2차 screening 하여 우수균주를 얻고 동정하였다. 우수균주의 5'-phosphodiesterase productivity에 대하여 배양상의 optimum condition을 검토하고 5'-phosphodiesterse activity에 미치는 여러 화합물의 영향과 효소반응의 최적 조건을 구명하였다. 우수균주가 생성한 5'-phosphodiesterase에 의하여 RNA 분해로 반응 최종 산물을 ion exchange column chromatography법으로 정량하고 최종 분해 산물엔 5'-mononucleotide를 paper chromatography, thinlayer chromatography, UV-absorption spectra, carbazole reaction 및 Schiff's reaction 등으로 동정한 결과는 다음과 같다. [1] 5'-phosphodiesterase productivity가 가장 우수한 두 균주를 선정하였고 이들은 토양에서 분리 되었으며 선정된 푸른 곰팡이는 Penicillium citreoviride PO 2-11로 동정되었고 방사선균은 Streptomyces aureus SOA 4-21로 동정되었다. [2] 분리 선정 된 Penicillium citreo-viride PO 2-11 strain은 배양상의 optimum condition 이 pH 5.0이고 temperature는 $30^{\circ}C$이었고 이 균이 생성한 5'-phosphodiesterase의 효소 반응상의 optimum condition 이 pH 4.2이고 temperature는 $60^{\circ}C$이었다. 그리고 5'-phosphodiesterase 생성에서 최적 탄소원은 sucrose이고 질소원은 $NH_4NO_3$이고 corn steep liquor나 혹은 yeast extract를 각각 0.01%씩 첨가한 구는 첨가하지 않은 control 구보다 20%의 5'-phosphodiesterase 생성 증가를 나타 내었다. 이 균이 생성한 5'-phosphodiestrase는 $Mg^{++},\;Ca^{++},\;Zn^{++},\;Mn^{++}$ 등 금속이온은 activator이고 EDTA, citrate, $Cu^{++},\;Co^{++}$ 등은 inhibitor 임을 알았다. 이 균이 생성한 5'-phosphodiesterase는 RNA를 분해하여 분해율 65.81%이었고 5'-AMP, 5'-GMP, 5'-UMP 및 5'-CMP를 생성하며 이때 축적되는 5'-mononucleotides중 5'-GMP 만이 정미성이 있음을 알았고 이균은 5'-AMP deamaminase가 없음을 확인하였다. 이 균의 효소에 의하여 RNA에서 정미성 5'-GMP 186.7 mg/RNA(g)를 생산할수 있음을 알았다. [3] 분리 선정된 Streptomyces aureus SOA 4-21 strain은 배양상의 optimum condition이 pH 7.0이고 temperature는 $28^{\circ}C$이었고 이 균이 생성한 5'-phosphodiesterase의 효소반응상의 optimum condition이 pH 7.3이고 temperature는 $50^{\circ}C$이었다. 그리고 5'-phosphodiesterase 생성에서 최적탄소원은 glucose이고 질소원은 asparagine이고 yeast extract 0.01%첨가구가 control 구보다 40%의 5'-phosphodiesterase 생성증가를 나타내었다. 이 균이 생성한 5'-phosphodiesterase는 $Ca^{++},\;Zn^{++},\;Mn^{++}$ 등 금속이온은 activator 이고 citrate, EDTA, $Cu^{++}$ 등은 inhibitor 임을 알았다. 또한 이 균은 5'-phosphodiesterase 뿐만 아니라 5'-AMP deaminase도 생성함을 확인하였다. 그러므로 RNA 분해율은 63.58% 이었고 RNA를 분해하여 5'-AMP, 5'-CMP, 5'-GMP 및 5'-UMP로 축적시키고 RNA가 효소 분해됨과 동시에 5'-AMP deaminase도 작용하며 생성된 5'-AMP 의 60% 상당을 5'-IMP로 전환시키는 특성이 있어서 정미성 5'-mononucleotide 생성이 전자의 균보다 두드러지게 증가함을 밝혔다. 이 균에 의하여 RNA에서 정미성 5'-IMP 171.8 mg/RNA(g) 및 5'-GMP 148.2 mg/RNA(g)생산할 수 있어 정미성 5'-mononucleotide 320mg/RNA(g)를 생산할 수 있음을 알았다.

  • PDF

Usage and perceptions of phosphodiesterase type 5 inhibitors among the male partners of infertile couples

  • Song, Seung-Hun;Kim, Dong Suk;Shim, Sung Han;Lim, Jung Jin;Yang, Seung Choul
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제43권1호
    • /
    • pp.26-30
    • /
    • 2016
  • Objective: We aimed to investigate the prevalence of erectile dysfunction (ED) and the usage of phosphodiesterase type 5 (PDE5) inhibitors for ED treatment in infertile couples. Methods: A total of 260 male partners in couples reporting infertility lasting at least 1 year were included in this study. In addition to an evaluation of infertility, all participants completed the International Index of Erectile Function (IIEF)-5 questionnaire to evaluate their sexual function. The participants were asked about their use of PDE5 inhibitors while trying to conceive during their partner's ovulatory period and about their concerns regarding the risks of PDE5 inhibitor use to any eventual pregnancy and/or the fetus. Results: Based on the IIEF-5 questionnaire, 41.5% of the participants (108/260) were classified as having mild ED (an IIEF-5 score of 17-21), while 10.4% of the participants (27/260) had greater than mild ED (an IIEF-5 score of 16 or less). The majority (74.2%, 193/260) of male partners of infertile couples had a negative perception of the safety of using a PDE5 inhibitor while trying to conceive. Only 11.1% of men (15/135) with ED in infertile couples had used a PDE5 inhibitor when attempting conception. Conclusion: ED was found to be common in the male partners of infertile couples, but the use of PDE5 inhibitors among these men was found to be very low. The majority of male partners were concerned about the risks of using PDE5 inhibitors when attempting to conceive. Appropriate counseling about this topic and treatment when necessary would likely be beneficial to infertile couples in which the male partner has ED.

일측성 요로폐쇄에 의한 실험적 신 간질 섬유화에서 Phosphodiesterase(PDE) 억제제의 항 섬유화 작용 (Antifibrotic Effects of Phosphodiesterase (PDE) Inhibitor in Experimental Interstitial Fibrosis induced by Unilateral Ureteral Obstruction.)

  • 하일수;엄은영;강희경;한혜원;박혜원;정해일;최용
    • Childhood Kidney Diseases
    • /
    • 제6권1호
    • /
    • pp.85-91
    • /
    • 2002
  • 서 론 : Phosphodiesterase (PDE) 억제제는 세포내 cAMP를 증가시키며, cAMP는 TGF-${\beta}1$에 의한 connective tissue growth factor (CTGF)의 발현을 억제하는 것으로 알러져 있다. 그러므로 저자들은 PDE 억제재가 TGF-${\beta}1$의 변화 없이 긴 섬유화를 억제할 수 있는지를 확인해 보고자 본 연구를 시행하였다. 방 법 : 백서에서 일측성 요관 결찰로 신 간질 섬유화를 유발하였다. 실험군에서는 PDE3 억제제인 cilostazol (1 g/L)이나 PDE5, PDE6, PDE8의 hybrid 억제제인 dipyridamole (750 mg/L)이 첨가된 음료수를 공급하였다. 일주일 후 신장을 적출하여 Masson-trichrome score를 평가하고, 신조직 조건배지에서 fibronectin과 TGF-${\beta}1$을 ELISA법으로 정량하였다. 결 과 : 대조군에 비해 cilostazol 군에서 Masson-trichrome score와 신조직 조건배지의 fibronectin 농도가 유의하게 낮았다(P<0.05). Dipyridamole군의 Masson-trichrome score와 조건배지의 fibronectin 농도도 대조군에 비해 낮아 보였으나 통계적 유의성을 보여주지 못했다. 신조직 조건배지의 TGF-${\beta}1$ 농도는 대조군, cilostazol군, dipyridamole군간에 차이가 없었다. 결 론 : 선택적 PDE3 억제제인 cilostazol은 TGF-${\beta}1$의 억제에 의존하지 않고 일측성 요로 폐쇄에 의한 신 섬유화를 억제하였다.

  • PDF

Simultaneous Determination of Synthetic Phosphodiesterase-5 Inhibitors in Dietary Supplements by Liquid Chromatography-High Resolution/Mass Spectrometry

  • Kim, So-Hee;Kim, Ho-Jun;Son, Jung-Hyun;Jeon, Byoung-Wook;Jeong, Eun-Sook;Cha, Eun-Ju;Lee, Jae-Ick
    • Mass Spectrometry Letters
    • /
    • 제3권2호
    • /
    • pp.50-53
    • /
    • 2012
  • After success of sildenafil for the treatment of erectile dysfunction, a large number of its analogues have been approved from FDA. Recently, the illegal dietary supplements which include sildenafil, vardenafil, tadalafil, or analogues of these drugs as ingredient have been widely distributed. Therefore, the determination of the residue of synthetic phosphodiesterase- 5 (PDE-5) inhibitors in dietary supplements is highly required due to indiscriminate and unintentional overdose caused nausea, chest pains, fainting and irregular heartbeat. In this paper, we report a rapid and sensitive analytical method for the simultaneous determination of nine phosphodiesterase-5 inhibitors by liquid chromatography-high resolution mass spectrometry. The present method was found to be accurate and reproducible with 40 ${\mu}g$/g of the limit of quantification for the nine PDE-5 inhibitors. The developed method can be successfully applied to the analysis of the seven illegal dietary supplements.

생쥐난자내 cAMP Phosphodiesterase의 활성에 미치는 억제제의 영향에 관한 연구 (Effects of Inhibitors on the Activity of cAMP Phosphodiesterase in the Mouse Oocytes)

  • 정민환;조완규
    • 한국동물학회지
    • /
    • 제29권2호
    • /
    • pp.79-85
    • /
    • 1986
  • 생쥐난자내에 cAMP phosphodiesterase(PDE)가 존재하는 가를 확인하고 cAMP PDE와 난자성숙간의 관계를 밝히기 위해 본 실험을 행하였다. 실험결과 생쥐난자내에는 Michaelis 상수 (Km)와 반응 최대속도 (Vmax)가 다른 두종의 cAMP PDE가 있다는 것이 밝혀졌다. 즉 하나는 Km 값이 $0.14 \\pm 0.01 \\muM$ 이고 Vmax 값이 $0.42 \\pm 0.07$ fmol cAMP hydrolyzed/oocyte/minute이고, 다른 하나는 Km 값이 $14.5 \\pm 2.0 \\muM$ 이고 Vmax 값이 $2.2 \\pm 0.5$ fmol cAMP hydrolyzed/oocyte/minute이다. 또한 PDE의 cAMP 분해작용은 난자성숙 억제제로 알려진 theophylline과 isobutyl-methylxanthine에 의해 저해되었으나 그 작용은 가역적이었다. 이 실험결과는 PDE의 활성저해로 인한 난자내의 cAMP의 축적이 결국 난자성숙을 억제하고 있다는 것을 암시하고 있다.

  • PDF